S810 Efficacy Outcomes by Symptom-Based Response Status After Induction: Week-48 Results from the GALAXI 1 Trial of Guselkumab in Crohn's Disease. (October 2022) - Panés, Julian; Rubin, David T.; Sands, Bruce E.; Reinisch, Walter; D'Haens, Geert; Sahoo, Aparna; Frustaci, Mary Ellen; Yang, Zijiang; Sandborn, William J.; Panaccione, Remo; Hisamatsu, Tadakazu; Danese, Silvio; et al.